{"name": "Bioenvision",
 "permalink": "bioenvision",
 "crunchbase_url": "http://www.crunchbase.com/company/bioenvision",
 "homepage_url": "http://www.bioenvision.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1996,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "212-750-6700",
 "description": "",
 "created_at": "Tue Mar 16 05:58:42 UTC 2010",
 "updated_at": "Wed Mar 27 03:34:29 UTC 2013",
 "overview": "\u003Cp\u003EBioenvision a biopharmaceutical company, engages in the acquisition, development, and marketing of compounds and technologies primarily for the treatment of cancer. Its lead products include Evoltra (clofarabine) which has marketing approval in both the European Union and United States for the treatment of pediatric relapsed or refractory acute lymphoblastic leukemia and Modrenal (trilostane), which has marketing approval in the United Kingdom for the treatment of post-menopausal breast cancer following relapse to initial hormone therapy.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "director ",
    "person":
     {"first_name": "Andrew",
      "last_name": "Schiff",
      "permalink": "andrew-schiff",
      "image":
       {"available_sizes":
         [[[95,
            144],
           "assets/images/resized/0026/5594/265594v1-max-150x150.jpg"],
          [[95,
            144],
           "assets/images/resized/0026/5594/265594v1-max-250x250.jpg"],
          [[95,
            144],
           "assets/images/resized/0026/5594/265594v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$7.41M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 7410000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 4,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SCO Capital Partners",
         "permalink": "sco-capital-partners",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Perseus",
         "permalink": "perseus",
         "image":
          {"available_sizes":
            [[[150,
               13],
              "assets/images/resized/0005/4753/54753v1-max-150x150.png"],
             [[250,
               22],
              "assets/images/resized/0005/4753/54753v1-max-250x250.png"],
             [[446,
               41],
              "assets/images/resized/0005/4753/54753v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aisling Capital",
         "permalink": "aisling-capital",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/6625/46625v1-max-150x150.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-250x250.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "345 Park Avenue, 41st Floor",
    "address2": "",
    "zip_code": "10154",
    "city": "New York",
    "state_code": "NY",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}